Cas:146824-79-5 6-methyl-3-phenylmethoxy-1-[3-(trifluoromethyl)phenyl]pyridazin-4-one manufacturer & supplier

Chemical Name:6-methyl-3-phenylmethoxy-1-[3-(trifluoromethyl)phenyl]pyridazin-4-one

CAS.NO:146824-79-5

Synonyms:4(1H)-Pyridazinone,6-methyl-3-(phenylmethoxy)-1-(3-(trifluoromethyl)phenyl);6-Methyl-3-(phenylmethoxy)-1-(3-(trifluoromethyl)phenyl)-4(1H)-pyridazinone

Molecular Formula:C₁₉H₁₅F₃N₂O₂

Molecular Weight:360.33000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:444.7ºC at 760 mmHg

Density:1.26g/cm3

Index of Refraction:1.555

PSA:44.12000

Exact Mass:360.10900

LogP:4.13870

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4(1H)-Pyridazinone,6-methyl-3-(phenylmethoxy)-1-(3-(trifluoromethyl)phenyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Methyl-3-(phenylmethoxy)-1-(3-(trifluoromethyl)phenyl)-4(1H)-pyridazinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4(1H)-Pyridazinone,6-methyl-3-(phenylmethoxy)-1-(3-(trifluoromethyl)phenyl) Use and application,4(1H)-Pyridazinone,6-methyl-3-(phenylmethoxy)-1-(3-(trifluoromethyl)phenyl) technical grade,usp/ep/jp grade.

Related News: The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. 6-methyl-3-phenylmethoxy-1-[3-(trifluoromethyl)phenyl]pyridazin-4-one manufacturer There are more than 4,700 different PFAS chemical compounds, researchers said. Since the 1950s, they have been widely used in a number of consumer products, including stain-repellent fabrics, nonstick cookware, polishes, waxes, paints and cleaning products, according to the U.S. Environmental Protection Agency. 6-methyl-3-phenylmethoxy-1-[3-(trifluoromethyl)phenyl]pyridazin-4-one supplier Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle �C from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products. 6-methyl-3-phenylmethoxy-1-[3-(trifluoromethyl)phenyl]pyridazin-4-one vendor At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity. 6-methyl-3-phenylmethoxy-1-[3-(trifluoromethyl)phenyl]pyridazin-4-one factory Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.